- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Trial Phase
Trial Status
Paid Participation
Clear All
Trial Details
Key Eligibility Criteria
2354 Participants Needed
Trial Details
Key Eligibility Criteria
1792 Participants Needed
Trial Details
Key Eligibility Criteria
82 Participants Needed
Trial Details
Key Eligibility Criteria
455 Participants Needed
Trial Details
Key Eligibility Criteria
1100 Participants Needed
Trial Details
Key Eligibility Criteria
288 Participants Needed
Trial Details
Key Eligibility Criteria
600 Participants Needed
Trial Details
Key Eligibility Criteria
275 Participants Needed
Trial Details
Key Eligibility Criteria
3177 Participants Needed
Trial Details
Key Eligibility Criteria
447 Participants Needed
Trial Details
Key Eligibility Criteria
608 Participants Needed
Trial Details
Key Eligibility Criteria
260 Participants Needed
Trial Details
Key Eligibility Criteria
529 Participants Needed
Trial Details
Key Eligibility Criteria
315 Participants Needed
Trial Details
Key Eligibility Criteria
1473 Participants Needed
Trial Details
Key Eligibility Criteria
1087 Participants Needed
Trial Details
Key Eligibility Criteria
1939 Participants Needed
Trial Details
Key Eligibility Criteria
3270 Participants Needed
Trial Details
Key Eligibility Criteria
5018 Participants Needed
Trial Details
Key Eligibility Criteria
247 Participants Needed
"As a healthy volunteer, I like to participate in as many trials as I'm able to. It's a good way to help research and earn money."
"I've been struggling with ADHD and anxiety since I was 9 years old. I'm currently 30. I really don't like how numb the medications make me feel. And especially now, that I've lost my grandma and my aunt 8 days apart, my anxiety has been even worse. So I'm trying to find something new."
"I was diagnosed with stage 4 pancreatic cancer three months ago, metastatic to my liver, and I have been receiving and responding well to chemotherapy. My blood work revealed that my tumor markers have gone from 2600 in the beginning to 173 as of now, even with the delay in treatment, they are not going up. CT Scans reveal they have been shrinking as well. However, chemo is seriously deteriorating my body. I have 4 more treatments to go in this 12 treatment cycle. I am just interested in learning about my other options, if any are available to me."
"My orthopedist recommended a half replacement of my right knee. I have had both hips replaced. Currently have arthritis in knee, shoulder, and thumb. I want to avoid surgery, and I'm open-minded about trying a trial before using surgery as a last resort."
"I've tried several different SSRIs over the past 23 years with no luck. Some of these new treatments seem interesting... haven't tried anything like them before. I really hope that one could work."
Trial Details
Key Eligibility Criteria
2014 Participants Needed
Trial Details
Key Eligibility Criteria
394 Participants Needed
Trial Details
Key Eligibility Criteria
4994 Participants Needed
Trial Details
Key Eligibility Criteria
10273 Participants Needed
Trial Details
Key Eligibility Criteria
2432 Participants Needed
Trial Details
Key Eligibility Criteria
600 Participants Needed
Trial Details
Key Eligibility Criteria
1450 Participants Needed
Trial Details
Key Eligibility Criteria
105 Participants Needed
Trial Details
Key Eligibility Criteria
152 Participants Needed
Trial Details
Key Eligibility Criteria
240 Participants Needed
Know someone looking for new options?
Spread the word
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across trials in Beloit, WI 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length in Beloit, WI is 12 months.
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility in Beloit, WI several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
Most recently, we added Sibeprenlimab for Sjögren's Syndrome, Cetuximab + Pembrolizumab for Head and Neck Cancer and Baxdrostat + Dapagliflozin for Chronic Kidney Disease and High Blood Pressure to the Power online platform.